SETD5
protein-codingSET domain containing 5, the group of SET domain containing
Gene summary
This function of this gene has yet to be determined but based on sequence similarity to other SET domain proteins it may function as a histone methyltransferase. Mutations in this gene have been associated with an autosomal dominant form of intellectual disability. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2017]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~81.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0014336
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014336
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014336
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0800439
Submitter: ClinGen
*SETD5* was first reported in relation to autosomal dominant syndromic complex neurodevelopmental disorder in 2013 (PMID: 24680889). Phenotypic features often reported in probands include: dysmorphic features, leg length discrepancies, feeding difficulties, developmental delays, autism, skeletal anomalies, and congenital malformations of various organ systems. This curation includes 19 variants (frameshift, deletions, missense, splice site) reported probands with phenotypic similarity (PMIDs: 28881385, 028120103, 28263952, 26482601, 29158550, 27375234, 32793091, 31656537, 29805509, 24680889, 25138099, 28549204). More evidence is available in the literature but the maximum score for genetic evidence (12 points) has been reached. Of note, three individuals with variants in *SETD5* and a distinct phenotype consistent with Moya Moya Disease, a rare, progressive cerebrovascular disorder caused by blocked arteries in the basal ganglia have also been reported, however that association has not been confirmed or reported again (PMID: 31474762). These individuals with Moya Moya did not have any neurodevelopmental delays and therefore were not scored in this curation. The mechanism of pathogenicity appears to be loss-of-function. In summary, there is definitive evidence supporting the relationship between *SETD5* and autosomal dominant syndromic complex neurodevelopmental disorder. This has been repeatedly demonstrated in the clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on the meeting date July 27, 2023 (SOP Version 9).
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SETD5 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_001080517.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 2 | 12 | 184 | 22 | 220 | |
| missense | 8 | 29 | 559 | 156 | 6 | 758 |
| nonsense | 52 | 25 | 5 | 1 | 83 | |
| start loss | 0 | |||||
| frameshift | 116 | 45 | 13 | 1 | 175 | |
| splice donor/acceptor (+/-2bp) | 14 | 18 | 9 | 41 | ||
| Total | 190 | 119 | 598 | 342 | 28 | 1277 |
Highest pathogenic variant AF is 0.000006369896
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_001073986.1 | 21 | MANE Select | |
| Ensembl | ENSP00000385852.2 | 21 | MANE Select | |
| RefSeq | NP_001278972.1 | 19 | Standard | |
| RefSeq | NP_001336380.1 | 19 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| setd5 | Danio rerio | Structure: head Quality: decreased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Histone Modifications
Biological Process
- covalent chromatin modification
- regulation of histone acetylation
- regulation of chromatin organization
Cellular Component
- nucleus
- nucleoplasm
- Cdc73/Paf1 complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000402198
- Coding exons
- 21
- Length
- 81626
- Individuals with no LoFs
- 124610
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 32
- Defined
- 124642
- p
- 0.000128
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.13 | 683 | 772 | 0.885 | 0.0000430 | 9258 |
| Missense (PolyPhen) | 177 | 311.9 | 0.56748 | 3567 | ||
| Synonymous | -0.684 | 296 | 281 | 1.05 | 0.0000144 | 2959 |
| Loss of Function | 6.70 | 9 | 69.1 | 0.130 | 0.00000434 | 803 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0010 | 0.0010 | notable |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00020 | 0.00020 | rare |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.000035 | 0.000035 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Probable transcriptional regulator that acts via the formation of large multiprotein complexes that modify and/or remodel the chromatin. Acts as a regulator of histone acetylation during gene transcription. {ECO:0000250|UniProtKB:Q5XJV7}.;
- Disease
- DISEASE: Mental retardation, autosomal dominant 23 (MRD23) [MIM:615761]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRD23 patients manifest moderate to severe intellectual disability with additional variable features of brachycephaly, a low hairline, depressed nasal bridge, prominent high nasal root, tubular nose, upslanting palpebral fissures, long and smooth philtrum, micrognathia, thin upper lip, and crowded teeth. Behavioral problems, including obsessive-compulsive disorder, hand flapping with ritualized behavior, and autism, are prominent features. {ECO:0000269|PubMed:24680889, ECO:0000269|PubMed:25138099, ECO:0000269|PubMed:27375234, ECO:0000269|PubMed:28549204}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- LoFtool
- 0.0174
- RVIS EVS
- -0.79
- RVIS percentile EVS
- 12.6
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.797
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |